Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-005698
Filing Date
2025-02-14
Accepted
2025-02-14 16:08:25
Documents
1
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739567298.html 4  
1 FORM 4 wk-form4_1739567298.xml 4 6795
  Complete submission text file 0001628280-25-005698.txt   8371
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AMICUS THERAPEUTICS 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Baldry Mark (Reporting) CIK: 0001644137 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 25628546